-
Sep 2021
In Vivo Expansion of Antigen-Specific Regulatory T Cells through Staggered Fc.IL-2 Mutein Dosing and Antigen-Specific Immunotherapy.
ImmunohorizonsPham MN, Khoryati L, Jamison BL, Hayes E, Sullivan JM, Campbell DJ, Gavin MA -
Sep 2021
High-throughput single-cell quantification of hundreds of proteins using conventional flow cytometry and machine learning.
Sci AdvBecht E, Tolstrup D, Dutertre CA, Morawski PA, Campbell DJ, Ginhoux F, Newell EW, Gottardo R, Headley MB -
Sep 2021
Approaches to Establishing Tolerance in Immune Mediated Diseases.
Front ImmunolHuffaker MF, Sanda S, Chandran S, Chung SA, St Clair EW, Nepom GT, Smilek DE -
Sep 2021
HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoantibody-positive early RA.
Arthritis Res TherRigby W, Buckner JH, Louis Bridges S Jr, Nys M, Gao S, Polinsky M, Ray N, Bykerk V -
Sep 2021
Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19.
PLoS PathogHeide J, Schulte S, Kohsar M, Brehm TT, Herrmann M, Karsten H, Marget M, Peine S, Johansson AM, Sette A, Lütgehetmann M, Kwok WW, Sidney J, Schulze Zur Wiesch J -
Sep 2021
Evaluating associations of joint swelling, joint stiffness and joint pain with physical activity in first-degree relatives of patients with rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA), a prospective cohort study.
BMJ OpenHughes-Austin JM, Ix JH, Ward SR, Weisman MH, ODell JR, Mikuls TR, Buckner JH, Gregersen PK, Keating RM, Demoruelle MK, Deane KD, Holers VM, Norris JM -
Sep 2021
PGD2 and CRTH2 counteract Type 2 cytokine-elicited intestinal epithelial responses during helminth infection.
J Exp MedOyesola OO, Shanahan MT, Kanke M, Mooney BM, Webb LM, Smita S, Matheson MK, Campioli P, Pham D, Früh SP, McGinty JW, Churchill MJ, Cahoon JL, Sundaravaradan P, Flitter BA, Mouli K, Nadjsombati MS, Kamynina E, Peng SA, Cubitt RL, Gronert K, Lord JD, Rauch I, von Moltke J, Sethupathy P, Tait Wojno ED -
Sep 2021
Optimal human pathogenic TH2 cell effector function requires local epithelial cytokine signaling.
J Allergy Clin ImmunolCalise J, Garabatos N, Bajzik V, Farrington M, Robinson D, Jeong D, Londei M, Wambre E -
Sep 2021
The parasite cytokine mimic Hp-TGM potently replicates the regulatory effects of TGF-β on murine CD4+ T cells.
Immunol Cell BiolWhite MPJ, Smyth DJ, Cook L, Ziegler SF, Levings MK, Maizels RM -
Sep 2021
Induction of stable human FOXP3+ Tregs by a parasite-derived TGF-β mimic.
Immunol Cell BiolCook L, Reid KT, Häkkinen E, de Bie B, Tanaka S, Smyth DJ, White MP, Wong MQ, Huang Q, Gillies JK, Ziegler SF, Maizels RM, Levings MK -
Sep 2021
Overview of oral tolerance induction for prevention of food allergy-Where are we now?
AllergyKrawiec M, Fisher HR, Du Toit G, Bahnson HT, Lack G -
Sep 2021
Evolution of epitope-specific IgE and IgG4 antibodies in children enrolled in the LEAP trial.
J Allergy Clin ImmunolSuarez-Farinas M, Suprun M, Bahnson HT, Raghunathan R, Getts R, duToit G, Lack G, Sampson HA -
Sep 2021
Thymic stromal lymphopoietin, skin barrier dysfunction, and the atopic march.
Ann Allergy Asthma ImmunolZiegler SF -
Aug 2021
Targeting Versican as a Potential Immunotherapeutic Strategy in the Treatment of Cancer.
Front OncolHirani P, Gauthier V, Allen CE, Wight TN, Pearce OMT -
Aug 2021
The Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4+ T Cells via a Novel CDK8-GATA3-FOXP3 Pathway.
Mol Cell BiolArnett A, Moo KG, Flynn KJ, Sundberg TB, Johannessen L, Shamji AF, Gray NS, Decker T, Zheng Y, Gersuk VH, Rahman ZS, Levy DE, Marié IJ, Linsley PS, Xavier RJ, Khor B
